WESTFORD, Mass., Nov. 10,
2016 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today
announced that President and Chief Executive Officer Michael Davin and Steve
Webber, the Company's Chief Financial Officer and Chief
Accounting Officer, will participate in the Stifel 2016 Healthcare
Conference at the Lotte New York Palace Hotel in New York City.
The event, which will be conducted in a "fireside chat" format,
is scheduled for 8:00 a.m. (ET)
Wednesday, November 16. Both live and archived audio
webcasts of the event will be accessible through a link on the
Investors section of the Company's website, www.cynosure.com.
About Cynosure, Inc.
Cynosure develops, manufactures
and markets aesthetic treatment systems that enable plastic
surgeons, dermatologists and other medical practitioners to perform
non-invasive and minimally invasive procedures to remove hair,
treat vascular and benign pigmented lesions, remove multi-colored
tattoos, revitalize the skin, reduce fat through laser lipolysis,
reduce cellulite, clear nails infected by toe fungus, ablate sweat
glands and improve women's health. The Company also markets
radiofrequency (RF) energy-sourced medical devices for precision
surgical applications such as facial plastic and general surgery,
gynecology, ear, nose, and throat procedures, ophthalmology, oral
and maxillofacial surgery, podiatry and proctology. Cynosure's
product portfolio is composed of a broad range of energy sources
including Alexandrite, diode, Nd: YAG, picosecond, pulse dye,
Q-switched lasers, intense pulsed light and RF technology. Cynosure
sells its products globally under the Cynosure, Palomar, ConBio and
Ellman brand names through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United
Kingdom, Australia,
China, Japan and Korea, and through international
distributors in approximately 120 other countries.
Contact:
Scott
Solomon
Senior Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cynosure-to-participate-in-stifel-2016-healthcare-conference-300360575.html
SOURCE Cynosure, Inc.